Novel Experimental Model of Pressure Overload Hypertrophy in Rats

Journal of Surgical Research

Volumn 153, Issue 2, 2009, Pages 287-294

  Molina, Ezequiel J ^a   Gupta, Dipin ^a   Palma, Jon ^a   Torres, Denise ^a   Gaughan, John P ^a   Houser, Steven ^a   Macha, Mahender ^b  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

aortic constriction; cardiac remodeling; exercise tolerance; experimental model of heart failure; pressure overload hypertrophy

Indexed keywords

ATRIAL NATRIURETIC FACTOR; INTERLEUKIN 1; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA CONSTRICTION; ARTICLE; BRACHIOCEPHALIC TRUNK; COHORT ANALYSIS; CONTROLLED STUDY; ECHOCARDIOGRAPHY; EXERCISE TOLERANCE; HEART FAILURE; HEART HEMODYNAMICS; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE PRESSURE; INFLAMMATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; UPREGULATION;

ANIMALS; AORTA; APOPTOSIS; BLOOD PRESSURE; CALCIUM; CONSTRICTION, PATHOLOGIC; DISEASE MODELS, ANIMAL; ECHOCARDIOGRAPHY; EXERCISE TEST; EXERCISE TOLERANCE; G-PROTEIN-COUPLED RECEPTOR KINASE 2; HEART FAILURE; HYPERTROPHY, LEFT VENTRICULAR; INFLAMMATION; MALE; RATS; RATS, SPRAGUE-DAWLEY; VENTRICULAR REMODELING;

EID: 64849087580     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2008.03.043     Document Type: Article

References (34)

1. Rosamond W., Flegal K., Furie K., et al., American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2008 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 29 (2008) 117 e25
2. Hasenfuss G. Animal models of human cardiovascular disease, heart failure, and hypertrophy. Cardiovasc Res 39 (1998) 60
3. Udelson J.E., and Konstam M.A. Relation between left ventricular remodeling and clinical outcomes in heart failure patients with left ventricular systolic dysfunction. J Card Fail 8 (2002) S465
4. Cohn J.N., Ferrari R., and Sharpe N. Cardiac remodeling-concepts and clinical implications: A consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling. J Am Coll Cardiol 35 (2000) 569
5. Carabello B.A. Concentric versus eccentric remodeling. J Card Fail 8 (2002) S258
6. Spotnitz H.M. Macro design, structure, and mechanics of the left ventricle. J Thorac Cardiovasc Surg 119 (2000) 1053
7. Fedak P.W., Verma S., Weisel R.D., et al. Cardiac remodeling and failure: From molecules to man, Part I. Cardiovasc Pathol 14 (2005) 1
8. Feldman A.M., Weinberg E.O., Ray P.E., et al. Selective changes in cardiac gene expression during compensated hypertrophy and the transition to cardiac decompensation in rats with chronic aortic banding. Circ Res 73 (1993) 184
9. Weinberg E.O., Schoen F.J., George D., et al. Angiotensin-converting enzyme inhibition prolongs survival and modifies the transition to heart failure in rats with pressure overload hypertrophy due to ascending aortic stenosis. Circulation 90 (1994) 1410
10. del Monte F., Butler K., Boecker W., et al. Novel technique of aortic banding followed by gene transfer during hypertrophy and heart failure. Physiol Genom 9 (2002) 49
11. Kiss E., Ball N.A., Kranias E.G., et al. Differential changes in cardiac phospholamban and sarcoplasmic reticular Ca(2+)-ATPase protein levels. Effects on Ca2+ transport and mechanics in compensated pressure-overload hypertrophy and congestive heart failure. Circ Res 77 (1995) 759
12. Koide M., Nagatsu M., Zile M.R., et al. Premorbid determinants of left ventricular dysfunction in a novel model of gradually induced pressure overload in the adult canine. Circulation 95 (1997) 1601
13. Aoyagi T., Fujii A.M., Flanagan M.F., et al. Transition from compensated hypertrophy to intrinsic myocardial dysfunction during development of left ventricular pressure-overload hypertrophy in conscious sheep. Systolic dysfunction precedes diastolic dysfunction. Circulation 88 (1993) 2415
14. Boluyt M.O., Robinson K.G., Meredith A.L., et al. Heart failure after long-term supravalvular aortic constriction in rats. Am J Hypertens 18 (2005) 202
15. Norton G.R., Woodiwiss A.J., Gaasch W.H., et al. Heart failure in pressure overload hypertrophy. The relative roles of ventricular remodeling and myocardial dysfunction. J Am Coll Cardiol 39 (2002) 664
16. Stoyanova V.K., Zhelev N.Z., Yanev I.B., et al. Time course and progression of pressure overload-induced cardiac hypertrophy in rats. Folia Med 47 (2005) 52
17. Okoshi M.P., Matsubara L.S., Franco M., et al. Myocyte necrosis is the basis for fibrosis in renovascular hypertensive rats. Braz J Med Biol Res 30 (1997) 1135
18. Dahl L.K., Heine M., and Tassinari L. Role of genetic factors in susceptibility to experimental hypertension due to chronic excess salt ingestion. Nature 194 (1962) 480
19. Pfeffer J.M., Pfeffer M.A., Fishbein M.C., et al. Cardiac function and morphology with aging in the spontaneously hypertensive rat. Am J Physiol 237 (1979) 461
20. Bing O.H., Brooks W.W., Robinson K.G., et al. The spontaneously hypertensive rat as a model of the transition from compensated left ventricular hypertrophy to failure. J Mol Cell Cardiol 27 (1995) 383
21. del Monte F., Williams E., Lebeche D., et al. Improvement in survival and cardiac metabolism after gene transfer of sarcoplasmic reticulum Ca(2+)-ATPase in a rat model of heart failure. Circulation 104 (2001) 1424
22. Musch T.I., Moore R.L., Riedy M., et al. Glycogen concentrations and endurance capacity of rats with chronic heart failure. J App Physiol 64 (1988) 1153
23. Musch T.I., Ghaul M.R., Tranchitelle S., et al. Skeletal muscle depletion during submaximal exercise in rats with chronic heart failure. Basic Res Cardiol 85 (1990) 606
24. Bristow M.R. β-Adrenergic receptor blockade in chronic heart failure. Circulation 101 (2000) 558
25. Morgan J.P. Abnormal intercellular modulation of calcium as a major cause of cardiac contractility dysfunction. N Engl J Med 325 (1991) 625
26. Kubo H., Margulies K., Piacentino V., et al. Patients with end-stage congestive heart failure treated with beta-adrenergic receptor antagonists have improved ventricular myocyte calcium regulatory protein abundance. Circulation 104 (2001) 1012
27. Jayasankar V., Woo J., Bish L., et al. Gene transfer of hepatocyte growth factor attenuates postinfarction heart failure. Circulation 108 Suppl 1 (2003) II230
28. Mann D.L., and Bristow M.R. Mechanisms and models in heart failure: The biomechanical model and beyond. Circulation 111 (2005) 2837
29. Levine B., Kalman J., Mayer L., et al. Elevated circulating levels of tumor necrosis factor in severe congestive heart failure. N Engl J Med 323 (1990) 236
30. Kerkela R., and Force T. p38 Mitogen-activated protein kinase: A future target for heart failure therapy?. J Am Coll Cardiol 48 (2006) 556
31. Latif N., Khan M.A., Birks E., et al. Up-regulation of the Bcl-2 family of proteins in end stage heart failure. J Am Coll Cardiol 35 (2000) 1769
32. Kang P.M., and Izumo S. Apoptosis and heart failure. Circ Res 86 (2000) 1107
33. Arai M., Matsui H., and Periasamy M. Sarcoplasmic reticulum gene expression in cardiac hypertrophy and heart failure. Circ Res 74 (1994) 555
34. Parsa C.J., and Koch W.J. Gene interventions in the β-adrenergic system for treating heart failure. Semin Thorac Cardiovasc Surg 15 (2003) 259